SRS33 - Human <i>versus</i> machine in survival prediction for metastatic spinal cord compression: a retrospective cohort study

Abstract Background Accurate survival prediction in metastatic spinal cord compression (MSCC) is critical for guiding treatment decisions, yet remains challenging, particularly for intermediate survival durations. We compared the accuracy of oncologist judgment, surgeon-calculated Tokuhashi scores, and ChatGPT-assisted predictions in estimating survival outcomes in MSCC patients. Methods This retrospective study included 99 consecutive patients referred to a tertiary spinal oncology center with radiologically confirmed MSCC. Anonymized clinical data were used to calculate surgeon Tokuhashi scores, document oncologist-estimated life expectancy, and generate ChatGPT-assisted survival predictions based on both literature review and Tokuhashi calculation. Predictions were compared against actual survival outcomes (&amp;lt;6 months, 6–12 months, &amp;gt;12 months). Machine learning analyses identified key predictors of survival. Results Overall prediction accuracies were 54% for ChatGPT Tokuhashi-based predictions, 50% for surgeon Tokuhashi scores, 48% for oncologist judgment, and 37% for ChatGPT literature-based estimates. Recall for short survival (&amp;lt;6 months) was highest with surgeon (71%) and ChatGPT Tokuhashi (69%) methods, whereas intermediate survival (6–12 months) remained difficult to predict across all modalities. Functional status (Karnofsky score) and patient age emerged as the strongest survival predictors across logistic regression, random forest, decision tree, and XGBoost models, surpassing primary tumor type and metastasis burden. Conclusions Structured prognostic tools and AI-assisted scoring can complement clinical judgment in predicting short-term survival in MSCC. However, intermediate-term survival prediction remains a critical unmet need. Future prognostic strategies should prioritize dynamic functional metrics over static tumor classifications to improve personalized decision-making.

Authors

Institutions

Publication Details

Journal
British journal of surgery
Published
2026-03-01
DOI
https://doi.org/10.1093/bjs/znag018.049
Primary Topic
Management of metastatic bone disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SRS33 - Human versus machine in survival prediction for metastatic spinal cord compression: a retrospective cohort study

A Hassan, Elie Najjar, Khalid Salem, Rodrigo Muscogliati et al.
British journal of surgery
Management of metastatic bone disease
article

SRS33 - Human versus machine in survival prediction for metastatic spinal cord compression: a retrospective cohort study

A Hassan, Elie Najjar, Khalid Salem, Rodrigo Muscogliati, N. A. Quraishi
article en

Abstract

Abstract Background Accurate survival prediction in metastatic spinal cord compression (MSCC) is critical for guiding treatment decisions, yet remains challenging, particularly for intermediate survival durations. We compared the accuracy of oncologist judgment, surgeon-calculated Tokuhashi scores, and ChatGPT-assisted predictions in estimating survival outcomes in MSCC patients. Methods This retrospective study included 99 consecutive patients referred to a tertiary spinal oncology center with radiologically confirmed MSCC. Anonymized clinical data were used to calculate surgeon Tokuhashi scores, document oncologist-estimated life expectancy, and generate ChatGPT-assisted survival predictions based on both literature review and Tokuhashi calculation. Predictions were compared against actual survival outcomes (&amp;lt;6 months, 6–12 months, &amp;gt;12 months). Machine learning analyses identified key predictors of survival. Results Overall prediction accuracies were 54% for ChatGPT Tokuhashi-based predictions, 50% for surgeon Tokuhashi scores, 48% for oncologist judgment, and 37% for ChatGPT literature-based estimates. Recall for short survival (&amp;lt;6 months) was highest with surgeon (71%) and ChatGPT Tokuhashi (69%) methods, whereas intermediate survival (6–12 months) remained difficult to predict across all modalities. Functional status (Karnofsky score) and patient age emerged as the strongest survival predictors across logistic regression, random forest, decision tree, and XGBoost models, surpassing primary tumor type and metastasis burden. Conclusions Structured prognostic tools and AI-assisted scoring can complement clinical judgment in predicting short-term survival in MSCC. However, intermediate-term survival prediction remains a critical unmet need. Future prognostic strategies should prioritize dynamic functional metrics over static tumor classifications to improve personalized decision-making.

British journal of surgeryVol. 113(Supplement_2)
Nottingham University Hospitals NHS Trust (GB), Leicester Royal Infirmary (GB)
Openalex Percentile: Top 4%
Management of metastatic bone disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.